People with very advanced melanoma (Stage IV) cannot be cured. These patients often enroll in clinical trials that test new and investigational therapies. There is no guarantee that an investigational therapy will be better than treatments already in use. A new treatment may also have unknown risks. But if a new treatment proves to be effective, patients in a clinical trial may be among the first people to benefit from it.
If you would like to learn more about clinical trials for investigational therapies for melanoma, visit www.clinicaltrials.gov.